A Review of Deep Learning Methods for Antibodies

Jordan Graves1, Jacob Byerly1, Eduardo Priego1

  • 1Macromoltek, Inc, 2500 W William Cannon Dr, Suite 204, Austin, Austin, TX 78745, USA.

Summary

Deep learning is revolutionizing antibody drug development by enabling the design of therapeutic biologics. This approach applies advanced algorithms to protein engineering for novel drug discovery.